1. Home
  2. SURG vs PMN Comparison

SURG vs PMN Comparison

Compare SURG & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SurgePays Inc.

SURG

SurgePays Inc.

N/A

Current Price

$1.71

Market Cap

47.6M

ML Signal

N/A

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

N/A

Current Price

$9.42

Market Cap

23.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SURG
PMN
Founded
2006
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Advertising
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.6M
23.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SURG
PMN
Price
$1.71
$9.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$9.50
$72.67
AVG Volume (30 Days)
109.5K
43.4K
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$50,372,555.00
N/A
Revenue This Year
$7.13
N/A
Revenue Next Year
$122.51
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.05
$6.27
52 Week High
$3.47
$39.75

Technical Indicators

Market Signals
Indicator
SURG
PMN
Relative Strength Index (RSI) 40.50 82.78
Support Level $1.40 $7.35
Resistance Level $1.90 $9.42
Average True Range (ATR) 0.16 0.68
MACD 0.02 0.18
Stochastic Oscillator 50.78 84.44

Price Performance

Historical Comparison
SURG
PMN

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: